George K. Ng

Insider Reports History

Location
San Diego, CA
Signature
/s/ Dan Dearborn as Power of Attorney for George Ng
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George K. Ng:

Company Role Class Num Shares Value Price $ Report Date Ownership
TuHURA Biosciences, Inc./NV Director Options (Right to Buy) 156,240 $114,055 $0.7300 12 Feb 2026 Direct
Calidi Biotherapeutics, Inc. Director Common Stock 18,542 $33,376 $1.80 12 Sep 2023 Direct
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 87,200 $18,312 $0.2100 24 Jul 2025 George Ng IRRA FBO: George Ng
Calidi Biotherapeutics, Inc. Director Common Stock 9,550 $17,190 $1.80 12 Sep 2023 By Peng Ventures, LLC
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Warrants 43,600 $9,156 $0.2100 24 Jul 2025 George Ng IRRA FBO: George Ng
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 20,000 $4,200 $0.2100 24 Jul 2025 Ng Cha Family Trust
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Options (Right to Buy) 768,000 01 Oct 2025 Direct
Processa Pharmaceuticals, Inc. Chief Executive Officer, Director Restricted Stock Units 256,000 01 Oct 2025 Direct

Insider Reports Filed by George K. Ng

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HURA TuHURA Biosciences, Inc./NV 12 Feb 2026 1 $0 4 Director 17 Feb 2026, 16:19
PCSA Processa Pharmaceuticals, Inc. 01 Oct 2025 2 $0 4 Chief Executive Officer, Director 03 Oct 2025, 16:23
PCSA Processa Pharmaceuticals, Inc. 24 Jul 2025 0 $0 4/A Chief Executive Officer, Director 18 Sep 2025, 16:21
PCSA Processa Pharmaceuticals, Inc. 27 Jan 2025 2 $0 4/A Chief Executive Officer, Director 18 Feb 2025, 17:53
HURA TuHURA Biosciences, Inc./NV 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:54
HURA Kintara Therapeutics, Inc. 18 Oct 2024 3 $0 4 Director 22 Oct 2024, 20:47
HURA Kintara Therapeutics, Inc. 18 Oct 2024 0 $0 3 Director 22 Oct 2024, 20:44
PCSA Processa Pharmaceuticals, Inc. 30 Jan 2024 1 +$27,000 4 Chief Executive Officer, Director 31 Jan 2024, 16:37
PCSA Processa Pharmaceuticals, Inc. 12 Oct 2023 1 +$25,000 4 Chief Executive Officer, Director 12 Oct 2023, 18:04
PCSA Processa Pharmaceuticals, Inc. 10 Oct 2023 1 +$25,000 4 Chief Executive Officer, Director 10 Oct 2023, 16:56
CLDI Calidi Biotherapeutics, Inc. 12 Sep 2023 0 $0 3 Director 25 Sep 2023, 18:39
PCSA Processa Pharmaceuticals, Inc. 08 Aug 2023 2 $0 4 Chief Executive Officer 09 Aug 2023, 16:51
PCSA Processa Pharmaceuticals, Inc. 08 Aug 2023 0 $0 3 Chief Executive Officer 09 Aug 2023, 16:47